Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

G. Schwartz, Gregory; Olsson, Anders; Abt, Markus; M. Ballantyne, Christie; J. Barter, Philip; Brumm, Jochen; Chaitman, Bernard; Holme, Ingar; Kallend, David; A. Leiter, Lawrence; Leitersdorf, Eran; J.V. McMurray, John; Mundl, Hardi; J. Nicholls, Stephen; K. Shah, Prediman; Tardif, Jean‐Claude; Scott Wright, R.

doi:10.1056/nejmoa1206797

Public

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Published in New England Journal of Medicine • Nov 5, 2012

Authors:

Gregory G. Schwartz

Anders Olsson

Markus Abt

Abstract

BACKGROUND: In observational analyses, higher levels of high-density lipoprotein (HDL) cholesterol have been associated with a lower risk of coronary heart disease events. However, whether raising HDL cholesterol levels therapeutically reduces cardiovascular risk remains uncertain. Inhibition of cho...

Subject

Acute coronary syndrome

Medicine

Cardiology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!